Evolving guidelines for intravitreous injections

Retina

Volumn 24, Issue 5 SUPPL., 2004, Pages

  Aiello, Lloyd P ^a   Brucker, Alexander J ^b,n   Chang, Stanley ^c   Cunningham Jr , Emmett T ^d   D'Amico, Donald J ^e   Flynn Jr , Harry W ^f   Grillone, Lisa R ^g   Hutcherson, Steve ^h   Liebmann, Jeffrey M ⁱ   O'Brien, Terrence P ^j   Scott, Ingrid U ^f   Spaide, Richard F ^k   Ta, Christopher ^l   Trese, Michael T ^m  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d OSI PHARMACEUTICALS INC   (United States)

^e MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g ISTA Pharmaceuticals Inc   (United States)

^h KKC   (United States)

ⁱ EAR AND THROAT HOSPITAL   (United States)

^j JOHNS HOPKINS UNIVERSITY   (United States)

^k VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

^l STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^m RETINA ^*

ⁿ Retina   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CEFAZOLIN; CEFTAZIDIME; CIPROFLOXACIN; CORTICOSTEROID; CYTOVINE; FLUOROURACIL; FOMIVIRSEN; GANCICLOVIR; GATIFLOXACIN; GENTAMICIN; HYALURONIDASE; LEVOFLOXACIN; MOXIFLOXACIN; MYDRIATIC AGENT; NEOSPORIN; OFLOXACIN; PEGAPTANIB; PENICILLIN DERIVATIVE; POVIDONE IODINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RANIBIZUMAB; SULFANILAMIDE; TISSUE PLASMINOGEN ACTIVATOR; TRIAMCINOLONE ACETONIDE; UNINDEXED DRUG; VANCOMYCIN; VASCULOTROPIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; AQUEOUS HUMOR; BLEPHARITIS; CLINICAL PRACTICE; CLINICAL PROTOCOL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CYTOMEGALOVIRUS INFECTION; DIABETIC RETINOPATHY; DRUG APPROVAL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG PENETRATION; DRUG SAFETY; ENDOPHTHALMITIS; EYE DISEASE; EYE INFECTION; EYELID DISEASE; FOOD AND DRUG ADMINISTRATION; GLAUCOMA; GLOVE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HYPOPYON; INJECTION; INTRAOCULAR HEMORRHAGE; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; INTRAVITREAL DRUG ADMINISTRATION; IRITIS; MINIMUM INHIBITORY CONCENTRATION; MYDRIASIS; OPPORTUNISTIC INFECTION; PATIENT MONITORING; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREOPERATIVE TREATMENT; RETINA DETACHMENT; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA HEMORRHAGE; RETINA VEIN OCCLUSION; RETINITIS; REVIEW; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; SKIN TEST; STAPHYLOCOCCUS EPIDERMIDIS; TRAUMATIC CATARACT; TREATMENT INDICATION; UVEITIS; VIRUS INFECTION; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 6344263392     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200410001-00002     Document Type: Review

References (39)

1. Jager RD, Aiello LP, Patel SC, Cunningham ET, Jr. Risks of intravitreous injection: a comprehensive review. Retina 2004, 24:676-698.
2. Ta CN. Minimizing the risk of endophthalmitis following intravitreous injections. Retina. Retina 2004, 24: 699-705.
3. Ohm J. Uber die behandlung der netzhautablosung durch operative entleerung der subretinalen flussigkeit und einspritzung von luft in den glaskorper. Albrecht von Graefes Arch Ophthalmol 1911;79:442-450.
4. Igersheimer J. Intraocular injection of sulfanilamide in a case of purulent iridocyclitis. Am J Ophthalmol 1943;26:1045-1047.
5. von Sallman L, Meyer K, DiGrandi J. Experimental study on penicillin treatment of ectogenous infection of vitreous. Arch Ophthalmol 1944;32:179-189.
6. Rycroft BW. Penicillin and the control of deep intraocular infection. Br J Ophthalmol 1945;29:57-62.
7. Henry K, Cantrill H, Fletcher C, Chinnock BJ, Balfour HH Jr. Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. Am J Ophthalmol 1987;103:17-23.
8. Blankenship GW. Evaluation of a single intravitreal injection of 5-fluorouracil in vitrectomy cases. Arch Clin Exp Ophthalmol 1989;227:565-568.
9. Blankenship GW. Evaluation of a single intravitreal injection of dexamethasone phosphate in vitrectomy surgery for diabetic retinopathy complications. Arch Clin Exp Ophthalmol 1991;229:62-65.
10. Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology 1999;106:1900-1906.
11. Kupperman BD, Thomas EL, Grillone LR, Chandler JW. Ovine hyaluronidase (Vitrase®, an investigational drug) reduces vitreous hemorrhage density (RVHD) and improves best corrected visual acuity (BCVA): Integrated results from 2 phase III studies. Presented at: Annual Meeting of the Association for Research in Vision and Ophthalmology. April 25-29, 2004; Ft. Lauderdale, Florida.
12. Maylath FR, Leopold IH. Study of experimental intraocular infection. I. The recoverability of organisms inoculated into ocular tissues and fluids. II. The influence of antibiotics and cortisone, alone and combined, on intraocular growth of these organisms. Am J Ophthalmol 1955;40:86-101.
13. Scott IU, Flynn HW Jr., Feuer W. Endophthalmitis after secondary intraocular lens implantation. A case-report study. Ophthalmology 1995;102(12):1925-1931.
14. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology 2002;109(1):13-24.
15. Benz MS, Scott IU, Flynn HW Jr., Unonius N, Miller D. Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol 2004;137: 38-42.
16. Isenberg SJ, Apt L, Yoshimori R, Khwarg S. Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic. Arch Ophthalmol 1985;103:1340-1342.
17. Apt L, Isenberg SJ, Yoshimori R, Spierer A. Outpatient topical use of povidone-iodine in preparing the eye for surgery. Ophthalmol 1989;96:289-292.
18. Rosenberg KD, Flynn HW Jr., Scott IU, Flynn PM, Miller D. In Vitro efficacy of fluoroquinolones for coagulase-negative staphylococcal endophthalmitis isolates. Presented at: Annual Meeting of Association for Research in Vision and Ophthalmology; April 25-29, 2004; Ft. Lauderdale, Florida.
19. Ta CN, Chang RT, Singh K, et al. Antibiotic resistance patterns of ocular bacterial flora: a prospective study of patients undergoing anterior segment surgery. Ophthalmology 2003;110(10):1946-1951.
20. Miller, D. Emerging resistance among ocular isolates. 2002. In house data, Bascom Palmer Eye Institute, Miami, Florida
21. Marangon FB, Miller D, Romano A, Alfonso EC. Emergence of quinolone resistance among methicillin sensitive Staphylococcus aureus keratitis and conjunctivitis isolates. Presented at: Annual Meeting of the Association for Research in Vision and Ophthalmology; May 5-10, 2002; Ft. Lauderdale, Florida.
22. Ritterband DC, Farquhar A, Shah M, Thimmappa S., Li J, Koplin R, Seedor J Are second generation fluroquinolone antibiotics losing their competitive edge in precataract surgery prophylaxis? Presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology. May 5-10, 2002; Ft. Lauderdale, Florida.
23. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 2002;133; 463-466.
24. Kowalski RP, Dhaliwal DK, Karenchak LM et al. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol 2003;136;500-505.
25. th generation fluoroquinolone penetration into aqueous. Presented at: Annual Meeting of the Association for Research in Vision and Ophthalmology; April 25-29, 2004; Ft. Lauderdale, Florida.
26. Solomon R, Donnenfeld E, Perry H, et al. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Presented at: Annual Meeting of the Association for Research and Vision in Ophthalmology; April 25-29, 2004; Ft. Lauderdale, Florida.
27. Katz HR, Lane S, Masket S, et al. Human aqueous humor concentrations of moxifloxacin following two multiple-dose topical ocular dosing regimens of Vigamox®. Presented at: Annual Meeting of the Association for Research in Vision and Ophthalmology; April 25-29, 2004; Ft. Lauderdale, Florida.
28. Stroman DW, Clark L, Macke L, et al. Moxifloxacin activity against quinolone resistant Staphylococcal ocular isolates. Invest Ophthalmol Vis Sci 2001,42(Suppl 4):1377.
29. Ta CN, Egbert PR, Singh K, Shriver EM, Blumenkranz MS, Mino de Kaspar HM. Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery. Ophthalmol 2002;109:2036-2041.
30. Mino de Kaspar H, Chang RT, Shriver EM, et al. Three-day application of topical ofloxacin reduces the contamination rate of microsurgical knives in cataract surgery: a prospective, randomized study. Ophthalmol. In press.
31. Ta CN, Egbert PR, Singh K, Blumenkranz MS, de Kaspar HM. The challenge of determining aqueous contamination rate in anterior segment intraocular surgery. Am J Ophthalmol 2004;137:662-667.
32. Bucci FA, Jr., Amico LM, Guerino A, Evans R. The effect of preop lid scrubs and levofloxacin on eyelid and conjunctival cultures prior to cataract surgery. Presented at: Annual Meeting of the Association for Research in Vision and Ophthalmology; May 4-9, 2003; Ft. Lauderdale, Florida.
33. Vitravene Study Group. Safety of intravitreous fomivirsen for treatment of cytomegalovirus retinitis in patients with AIDS. Am J Ophthalmol. 2002;133:484-496.
34. Gragoudas ES. VEGF inhibition study in ocular neovascularization-1 (VISION-1): Efficacy results from phase II/III Macugen™ (peganatib sodium) clinical trials. Presented at: Annual Meeting of the Association for Research in Vision and Ophthalmology; April 25-28, 2004; Ft. Lauderdale, Florida.
35. Apt L; Isenberg S; Yoshimori R; Paez JH. Chemical preparation of the eye in ophthalmic surgery. III. Effect of povidone-iodine on the conjunctiva. Arch Ophthalmol 1984;102:728-729.
36. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology 1991;98:1769-1775.
37. Binder C, de Kaspar HM, Engelbert M, Klauss V, Kampik A. Bacterial colonization of conjunctiva with Propionibacterium acnes before and after polyvidone iodine administration before intraocular interventions. Ophthalmology 1998;95:438-441.
38. Binder CA, Mino de Kaspar H, Klauss V, Kampik A. Preoperative infection prophylaxis with 1% polyvidone-iodine solution based on the example of conjunctival staphylococci. Ophthalmology 1999;96:663-667.
39. Mino de Kaspar H, Chang R, Egbert P, et al. Greater elimination of conjunctiva bacteria after preoperative irrigation with 10cc of 5% povidone-iodine. Presented at: Annual Meeting of the American Academy of Ophthalmology. November 15-18, 2003; Anaheim, Florida.